Officials from
Eisai
, a pharmaceutical firm based in New Jersey, broke ground Monday for a production and formulation facility that will cost $90 million. The building will cover 65,000 square feet.
Eisai also will build a $15 million utilities building to supply power, chilled water and compressed air for plant operations.
The new facilities will lead to the creation of 84 jobs over the next five years.
Eisai announced the expansion plans earlier this year after receiving $1 million in incentives from Durham County and another $150,000 from the state.
The new main facility will be used for development and production of intravenous oncology treatments.
"Today's groundbreaking is a testament to our long-standing commitment to oncology as well as our exceptional growth since we first broke ground in RTP 10 years ago," said Lonnel Coats, president and chief operating officer of Eisai. "We are dedicated to fulfilling our human health-care mission of satisfying unmet medical needs and increasing benefits to patients with cancer."
Eisai has maintained a presence in RTP for 10 years. The new expansion is the third announced by the company in RTP. It employs some 1,300 people at corporate headquarters in Teaneck, N.J., and in RTP. Eisai is based in Japan, where it is the fourth-largest pharmaceutical firm.
Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
